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Abstract
Background: Health risk from exposure of perfluorochemicals (PFCs) to wildlife and human has
been a subject of great interest for understanding their molecular mechanism of toxicity. Although
much work has been done, the toxigenicity of PFCs remains largely unknown. In this work, the non-
covalent interactions between perfluorooctane sulfonate (PFOS) and serum albumin (SA) and DNA
were investigated under normal physiological conditions, aiming to elucidate the toxigenicity of
PFCs.
Results: In equilibrium dialysis assay, the bindings of PFOS to SA correspond to the Langmuir
isothermal model with two-step sequence model. The saturation binding number of PFOS was 45
per molecule of SA and 1 per three base-pairs of DNA, respectively. ITC results showed that all
the interactions were spontaneous driven by entropy change. Static quenching of the fluorescence
of SA was observed when interacting with PFOS, indicating PFOS bound Trp residue of SA. CD
spectra of SA and DNA changed obviously in the presence of PFOS. At normal physiological
conditions, 1.2 mmol/l PFOS reduces the binding ratio of Vitamin B2 to SA by more than 30%.
Conclusion: The ion bond, van der Waals force and hydrophobic interaction contributed to PFOS
binding to peptide chain of SA and to the groove bases of DNA duplex. The non-covalent
interactions of PFOS with SA and DNA alter their secondary conformations, with the physiological
function of SA to transport Vitamin B2 being inhibited consequently. This work provides a useful
experimental method for further studying the toxigenicity of PFCs.
Background
Biomolecules such as proteins and DNA have been a sub-
ject of great interest for the last hundreds of years because
of their key functional roles in the cellular processes.
Serum albumin is the major protein component of blood
plasma. It is responsible for the maintenance of oncotic
pressure of blood plasma [1] as well as that of blood pH
[2]. It is the well-known model protein and is called a
multifunctional plasma carrier protein for its ability to
bind a wide variety of ligands. These include inorganic
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cations, organic anions, amino acids, and, perhaps most
important, physiologically available insoluble endog-
enous compounds, e.g., fatty acids [3-7], bilirubin [1],
and bile acids. The locations of the fatty acid binding sites
throughout the protein have been mapped by structural
study [6,7]. In fact, not only endogenous ligands but also
exogenous compounds bind to HSA, for example, com-
monly used drugs with acidic or electronegative features,
e.g., warfarin [8], camptothecins [9] and inorganic poly-
mers such as polyoxometalates [10]. Recently, the binding
mechanism of organic contaminants or toxins to HSA has
been investigated, e.g. arazine [11], ochratoxin [12],
methyl parathion [13], and arsenic [14]. The interactions
of organic contaminants with serum albumin often cause
conformational change in the protein or even the subse-
quent change of its physiological function. Concerning to
DNA, whose conformation and sequence preference is
critical to replication, transcription and DNA chromatin
compaction [15], it is reported that DNA is subjected to
the effect of organic chemicals, too, whether it is endog-
enous ligands or exogenous compounds. As the target of
many drugs [16,17] and also most likely of a large number
of environmental pollutants [18,19], DNA has been
extensively studied about the binding mechanism such as
minor groove binding, major groove binding, and
(bis)intercalation. For example, Distamycin A, a well-
known polyamide antibiotic, can bind in the minor
groove of duplex DNA primarily at AT-rich sequences as a
monomer or as a side-by-side antiparallel dimer. Its bind-
ing affinity derives from specific hydrogen bonding con-
tacts between the amide protons and the O2 or N3 of
pyrimidines and purines, respectively, electrostatic inter-
actions with the backbone, and van der Waals contacts
with the walls of the minor groove [20]. In fact, the
involvement of any substances is likely to affect the activ-
ity of the biomolecule, either enhancing it [21] with
potential medical significance or inhibiting it [22] if it is
associated with an organic contaminant or toxin. After all,
there is still a lot unknown about the binding mechanism
of biomolecules.
For over half a century, perfluorochemicals (PFCs) have
been extensively used in a variety of consumer and indus-
trial applications due to their physical and chemical prop-
erties: chemical stability, thermal inertness, low surface
energy and an amphiphilic nature [23,24]. Given their
physical and chemical properties, PFCs have been found
not only persistent in the environment, bioaccumulative
through food chain but also ubiquitously distributed all
over the world [25-35] including the Arctic, Antarctic and
Pacific region. Several studies have been conducted on the
presence and levels of PFCs in marine mammals, fish,
birds, and humans [25-35]. PFOS were found in high con-
centrations in liver tissue in top predators, polar bears,
and even in the cord serum of newborns in many coun-
tries [33,36-38]. Recently, PFCs have been identified as
new persistent organic pollutants [39]. Laboratory studies
have reported the developmental and reproductive toxic-
ity [40-45], neurotoxicity [46-49], immunotoxicity
[50,51] and carcinogenicity [52,53] of PFOS in rodents
both in vivo and in vitro. At cellular, molecular and gene
levels, PFOS was found to cause peroxisomal proliferation
[54,55], change of membrane surface potential [56],
mitochondrial dysfunction [57], disturbance of fatty acid
metabolism [58], hepatocellular hypertrophy [59] and
even change of gene expression [60]. In 2000, 3 M, the
major manufacturer of these compounds, announced the
discontinuation of its perfluorooctane-based compounds
due to concerns regarding persistence, worldwide dissem-
ination, toxicity, and bioaccumulation.
Elucidation of the mechanism of biomolecular interac-
tions such as protein-protein [61] and DNA-ligand bind-
ing [16,17], enzyme catalysis, and inhibition is crucial to
understanding of cellular processes including signal trans-
duction, gene regulation, and enzyme reactions [62].
Conventional molecular spectrometric methods such as
fluorescent probe, UV, and circular dichroism (CD) have
been widely used for the investigation of protein-ligand
interaction. Recently, binding mechanisms have been
studied using equilibrium dialysis, x-ray crystallography,
NMR, isothermal titration calorimetry (ITC), and surface
plasmon resonance biosensors [63,6,64,17,65], which are
powerful analytical tools in enzymology, rational drug
design, and toxicology. In this study, equilibrium dialysis,
fluorophotometry, ITC and CD were used to characterize
the non-specific interactions between PFOS and SA/DNA
in the normal physiological condition, pH 7.4 and 0.15 M
electrolyte and 37°C. The object is to analyze the interac-
tion forces, sites and type and then further understand the
toxigenicity of PFCs.
Results and discussion
Characterization of the interactions of PFOS with SA and 
DNA
HPLC-MS was used to validate the simple colorimetric
detection method for the determination of PFOS during
dialysis process. The two methods have achieved the con-
sistent results in the measurement of three PFOS dialysis
solutions (see Additional File 1). Therefore, the colorimet-
ric method is feasible for the determination of PFOS in the
present work. The interaction of PFOS (L) with SA and
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Both cL0 and cM0 are the initial concentrations of PFOS and
of SA or DNA pipeted into dialysis bags. The symbol cL is
the equilibrium concentration of PFOS, N the saturation
binding number of PFOS, Kb the binding constant. Con-
sidering PFOS was diluted 4 times during the equilibrium
dialysis, the effective fraction (f) and the molar ratio (γ) of
PFOS bound to SA or DNA can be calculated by the rela-
tionships below [66]:
and
It can be deduced that
By measuring a series of PFOS solutions containing
known concentrations of SA or DNA, γ was calculated
using Eq. 4. As is shown in Fig. 1A, the γ value increases
with increasing PFOS concentration. The Langmuir iso-
thermal model below was used to fit the experimental
data.
where K is the adsorption constant. The plots of γ-1 versus
cL
-1 are shown in Fig. 1B. The good linear relationships of
the plots indicate that the bindings of PFOS to peptide
chains and DNA duplex obey the Langmuir isothermal
model. The interactions of PFOS with SA and DNA are the
chemical adsorption in monolayer. From the intercepts of
the regression lines in Fig. 1B, N  of PFOS molecules
bound per molecule of SA and per bp of DNA was calcu-
lated to be 45 and 0.36, respectively.
The electrostatic attraction plays an important role in the
binding of sulfonic ligands to proteins. Several studies in
our laboratory have revealed that electrostatic attraction
between the sulfonic groups of azo compounds and the
positively charged amino acid residues (AARs) of SA is the
main contributor that fixes the position of these com-
pounds in protein in acidic media and induces the subse-
quent combined actions of multiple non-covalent bonds,
e.g., hydrogen bonds, hydrophobic interactions and van
der Waals force [67,68]. Given the dissociation constants
(KR) of the side groups (R) of basic and acidic AARs of SA
(10.53 for Lys, 6.00 for His, 12.48 for Arg, 3.65 for Asp,
and 4.25 for Glu), only the side groups of Lys and Arg res-
idues are protonated and positively charged in neutral
solutions in our study, so selectrostatic attraction between
the sulfonic acid group of PFOS and positively charged
AARs of SA will be much weaker than that in acidic media.
But concerning the high polarity of PFOS, the electrostatic
attraction between the sulfonic acid group of PFOS and
the positively charged -NH3
+ groups of Lys and Arg of SA
can still play an important role in the PFOS-SA binding
[69,70]. Moreover, the hydrophobic interaction will also
occur between the long alkyl group of PFOS and the non-
polar side groups of AARs of SA such as Lys, Arg, His and
so on. Similarly, PFOS may bind to DNA via hydrophobic
interaction resulting from the long alkyl group and the
homolateral bases in the groove of DNA.
Effects of pH, electrolytes and temperature
The stability of non-covalent interaction is always affected
by various environmental conditions such as pH, ionic
strength and temperature [71,72]. As is shown in Fig. 2A,
γ for the PFOS-SA binding decreases obviously with
increasing pH. It implies that the acidic media are more
favorable for PFOS binding to SA. As we know from the
dissociation constants (KR) of the side groups (R) of basic
and acidic AARs of SA, more side groups (R) of AARs are
protonated and positively charged in acidic media. Thus,
the electrostatic attraction between the sulfonic acid head
of PFOS and the positively charged AARs will be much
stronger than that in neutral media [67,68], which result
in the increasing of binding number of PFOS to SA. More-
over, SA tends to unfold in acidic media, so steric hin-
drance decreases, leading to an increasing of possible
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Plots of (A) γ vs. cL0 and (B) γ-1 vs. cL
-1 for the PFOS solutions  containing 0.02 mmol/l SA (1) and 0.96 mmol/l DNA (2) at  pH7.40 at 37°C in the presence of 0.15 mol/l NaCl Figure 1
Plots of (A) γ vs. cL0 and (B) γ-1 vs. cL
-1 for the PFOS 
solutions containing 0.02 mmol/l SA (1) and 0.96 
mmol/l DNA (2) at pH7.40 at 37°C in the presence of 
0.15 mol/l NaCl.BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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increasing binding is obviously observed at pH 2. Similar
to SA, DNA tends to unfold in acidic media, too. The
increasing of possible binding sites resulting from the
unfolding of DNA may be the reason that PFOS-DNA
binding number increases. In addition, a peak of γ appears
at pH 7.4 for the PFOS-DNA binding and then γ decreases
at pH 8.4 and 9.4 afterwards. It implies the neutral media
is comparatively more favorable for PFOS binding, indi-
cating the potential risk of PFOS toxicity under the physi-
ological condition of wildlife and human.
Sodium chloride was added in the PFOS-SA/DNA solu-
tions to investigate the effect of electrolyte on the non-
covalent interaction. Human blood normally contains
approximately 0.15 mol/l electrolyte. Although γ of PFOS-
SA binding (Fig. 2B) increases when the electrolyte is less
than 0.15 mol/l, γ is only slightly different in 0.15 mmol/
l electrolyte from that in 0.25 mol/l electrolyte. This
implies that ions in human blood would not affect PFOS
binding. From the curves in Fig. 2B, a peak of γ of the
PFOS-DNA binding appears at 0.25 mol/l electrolyte,
indicating that ions in body fluids will affect the PFOS-
DNA binding more or less.
High temperature has two opposing effects on non-cova-
lent interaction. On one hand, the peptide chain and
DNA duplex will expand with heating and the three-
dimensional conformation will be favorable for the inser-
tion of organic molecules. On the other hand, such expan-
sion will increase the distance between peptide chains and
DNA duplex, leading to the redistribution of the effective
binding sites on the peptide chain and DNA duplex and
the subsequent desorption of small organic substances
[73]. The balance between these mechanisms decides the
effect of temperature on the non-covalent interactions. As
is shown in Fig. 2C, γ values for the PFOS-SA/DNA inter-
actions decrease with increasing of temperature. Obvi-
ously the distance between the peptide chains or DNA
duplex increases as a result of temperature increase and
lead to the desorption of PFOS, which result from the sub-
sequent decrease of binding sites for PFOS. Therefore, γ
values of the PFOS-SA/DNA interactions decrease.
The intrinsic fluorescence analysis of Trp residues of SA
The intrinsic fluorescence analysis of tryptophan residue
(Trp) of SA is often used in the investigation of a ligand-
protein binding. The quenching of protein fluorescence
depends on the degree of exposure of Trp residue to the
polar, aqueous solvent and its proximity to specific
quenching groups such as protonated carboxyl, proto-
nated imidazole and deprotonated ε-amino groups [74].
Two models have been proposed for the quenching of
protein fluorescence: static quenching and dynamic
quenching [75]. In static quenching, the quencher binds
to Phe, Tyr, especially Trp residues of SA and consequently
the compound in ground state that has no fluorescence is
formed, resulting in the decrease in the fluorescence
intensity of SA. On the contrary, in dynamic quenching
the decrease in the fluorescence intensity of SA is only
because of the molecular collision between the quencher
and SA. Higher temperatures usually result in faster diffu-
sion, collision and hence larger amounts of dynamic
quenching. In order to confirm the quenching mecha-
nism, the fluorescence quenching data presented here was
assumed to be dynamic quenching. The classical relation-
ship often employed to describe the dynamic quenching
process is the Stern-Volmer equation:
Where F0 is the fluorescence intensity of SA without PFOS,
F is the fluorescence intensity of SA in the presence of
PFOS, τ0 is the lifetime of the fluorophore of SA in the
absence of quencher, usually 10-8 s for biomolecule, and
Q is the concentration of PFOS (mol/l), the quencher, Kq
is the bimolecular quenching rate constant and 2.0 × 1010
l/(mol·s) is the highest value of Kq for dynamic quench-
ing. In this study if Kq, PFOS-SA (Kq for PFOS-SA binding) is
calculated to be much larger than 2.0 × 1010 l/(mol·s),
static quenching occurs for PFOS-SA binding; if Kq, PFOS-SA
is calculated to be less than 2.0 × 1010 l/(mol·s), dynamic
quenching occurs. By regression of plots F0/F vs Q (Fig.
3B), the relationship y = 0.0436x + 0.962 (R = 0.9903) was
arrived. The Kqτ0 value could be equivalent to 0.0436
(PFOS in umol/l in Fig. 3B). Kq, PFOS-SA is calculated to be
4.36 × 1012 l/(mol·s), which is much greater than the
highest dynamic quenching constant, 2.0 × 1010l/
(mol·s). So the interaction between PFOS and SA resulted
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Effects of pH (A), electrolyte (B) and temperature (C) on γ of  solutions containing 0.8 mmol/l PFOS, 0.016 mmol/l SA (A  and B) and 0.02 mmol/l SA (C), 0.9 mmol/l DNA (A) and 1.19  mmol/l DNA (B and C) Figure 2
Effects of pH (A), electrolyte (B) and temperature 
(C) on γ of solutions containing 0.8 mmol/l PFOS, 
0.016 mmol/l SA (A and B) and 0.02 mmol/l SA (C), 
0.9 mmol/l DNA (A) and 1.19 mmol/l DNA (B and C).BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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SA were obtained in the presence of PFOS (Fig. 3A). Not
only a gradual decrease in the fluorescence intensity of SA
but also a blue shift (10 nm) in the emission wavelength
were observed, indicating that PFOS bound to the Trp res-
idue, W214 of SA and the microenvironment around Trp,
Phe and Tyr residues was changed consequently. This phe-
nomenon confirmed the occurrence of static quenching
between PFOS and SA again.
SA contains a hydrophobic cavity and all hydrophobic
AARs were present in the cavity [76], including Trp resi-
due, which is favorable for hydrophobic group to enter.
PFOS enters the cavity and interacts with the hydrophobic
AARs via hydrophobic interaction between the alkyl
group of PFOS and the aromatic group of AARs, causing
the quenching of SA fluorescence. In addition, concerning
the high polarity of the sulfonic acid group of PFOS, the
electrostatic attraction could occur between the sulfonic
acid group of PFOS and -NH3
+ of Lys and Arg residues of
SA.
Variation of the secondary conformation of SA and DNA
The combinations of covalent and non-covalent interac-
tions among a protein or DNA result in the specific con-
formation and the corresponding function of
biomolecules. When organic compounds such as a pollut-
ants, drugs or toxicants interact with protein or DNA, the
internal non-covalent bonds of the peptide chain or DNA
duplex are often disrupted, possibly changing the original
conformation or even their special function. CD spec-
trometry is often used to evaluate the secondary structure
of DNA [77] or a protein [68], such as the fractions of β-
pleated sheet, α-helix and β-turn.
The molar ellipticity CD curves of PFOS-SA/DNA solu-
tions are given in Fig. 4. As is shown in Fig. 4B, the frac-
tions of β-pleated sheet, α-helix, and β-turn of SA changed
obviously in the presence of PFOS. With the addition of
PFOS, the β-pleated sheet fraction of SA decreases from
20.2% to 11.3% whereas that of α-helix and β-turn
increases from 22.8 to 26.1% and 26.5 to 29.8%, respec-
tively. Obviously the disappearance of β-pleated sheet
results in the increase of α-helix and β-turn content.
Although in neutral solutions the non-covalent bonds
between PFOS and SA are much weaker compared with
that in acidic solutions [67,68], the addition of PFOS
causes obvious change of secondary structure of SA. From
the data above, the addition of PFOS transforms some β-
pleated sheet into α-helix and β-turn.
The CD spectra of DNA in the 230–300 nm scope show a
signal characteristic of a B-form helix with a negative band
at 245 nm and a positive band at 275 nm. The enhance-
ment of CD spectra at both 245 and 275 nm in the pres-
ence of PFOS and the shape change of the positive and
negative band (Fig 4C) indicated that PFOS binds in the
groove of DNA. On account of the hydrophobic alkyl
(A) The fluorescence spectra of solutions containing 0.5  μmol/l SA and variable PFOS from 1 to 8: 0, 2.5, 5, 7.5, 10,  12.5, 15, 17.5 μmol/l at pH7.40 Figure 3
(A) The fluorescence spectra of solutions containing 
0.5 μmol/l SA and variable PFOS from 1 to 8: 0, 2.5, 
5, 7.5, 10, 12.5, 15, 17.5 μmol/l at pH7.40. (B) Plot of F0/
F vs. Q for the SA-PFOS solutions.
The molar ellipticity CD curves of solutions containing (A)  0.4 μmol/l SA in the presence of PFOS from 1 to 5: 0, 16, 20,  24, 40 μmol/l and (C) 100 μmol/l DNA with PFOS from 1 to  4: 0, 20, 30, 40 μmol/l; (B) Plot of fraction (%) vs. C0, PFOS for  the SA-PFOS solutions Figure 4
The molar ellipticity CD curves of solutions contain-
ing (A) 0.4 μmol/l SA in the presence of PFOS from 1 
to 5: 0, 16, 20, 24, 40 μmol/l and (C) 100 μmol/l DNA 
with PFOS from 1 to 4: 0, 20, 30, 40 μmol/l; (B) Plot 
of fraction (%) vs. C0, PFOS for the SA-PFOS solutions. 
All solutions were prepared at pH7.40.BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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group of PFOS, PFOS may bind in the groove of DNA par-
alleling with the phosphate backbone via van der Waals
force and hydrophobic interaction. Thus, the electron
cloud of bps becomes expanding owing to the reversed
pulling of PFOS so as to the enhancement of CD of DNA
at 275 nm.
Thermodynamic characterization of the interactions of 
PFOS with SA and DNA
Relating thermodynamic parameters to structural and
biochemical data allows a better understanding of the
mechanism of the biomolecule-ligand reaction. The ITC
measurements provide information on thermodynamic
quantities such as enthalpy and heat capacity changes dur-
ing the molecular interaction based on the heat produced
by reactions In recent years, ITC measurements have been
widely applied to study e.g. protein-ligand interaction
[78], DNA-ligand interaction [77].
The ITC experiments were conducted by injecting PFOS
solutions into the ITC cell containing SA or DNA in pH
7.40 media at 37°C. In each experiment, an exothermic
heat pulse was detected following each injection. Its mag-
nitude progressively decreased until a plateau is reached
indicating saturation of binding. The heat involved at
each injection was corrected for the heat of dilution,
which was determined separately by injecting the PFOS
solutions into the B-R buffer and then divided by the
number of moles injected. Values for the equilibrium
binding constant (Kb), enthalpy change (ΔH), and
entropy change (ΔS) of the reaction were obtained and
calculated by the Gibbs free energy (ΔG) equation:
ΔG = -RTln KD = ΔH - TΔS (7)
As is shown in Fig. 5, all ΔH are much less than 60 kcal/
mol, so the PFOS-SA/DNA interactions are non-covalent
[79], involving the electrostatic attraction, hydrophobic
interaction, and van der Waals force. Moreover, the heat
released from both PFOS-SA (Fig. 5A) and PFOS-DNA
(Fig. 5B) interactions approaches zero when cL0/cM0 > 10
and 0.3, respectively, indicating the plateau is being
reached. All the reactions are driven by entropy change
and thus spontaneous because ΔH is much less than that
-TΔS (Fig. 5B-2).
SA is composed of three homogenous and helical
domains (Fig. 6A). Every domain consists of two sub-
domains, which face each other like two notches. All the
hydrophobic amino acid residues embedded in the sub-
domains formed three hydrophobic cavities [2]. During
protein-ligand interaction, polar bonds are likely to be
formed outside of the hydrophobic cavities because polar
residues of SA predominate here. The reactions are usually
exothermic due to the high energy of polar bond. On the
contrary, hydrophobic interactions are likely to occur
inside of the hydrophobic cavity. The reactions are usually
endothermic with the folding of protein and decreasing of
entropy change.
From Fig. 5A, the binding of PFOS to SA corresponds to
two-step sequence model: on the surface and inside the
cavity. First, the heat released from PFOS-SA interactions
was negative when cL0/cM0 < 10, indicating the occurrence
of exothermic reaction and the formation of polar bonds.
Because the polar bonds are more likely to be formed out-
side of the hydrophobic cavity of SA, it is suggested that
ITC titration curves of (A) PFOS-SA and (B) PFOS-DNA  interactions at pH7.40 Figure 5
ITC titration curves of (A) PFOS-SA and (B) PFOS-
DNA interactions at pH7.40. The temperature was 
37°C. The experiment was conducted by injecting: 2.5 mmol/
l PFOS (10 μl every time) into the ITC cell (1.4685 ml) con-
taining (A) 0.01 mmol/l SA or (B) 0.5 mmol/l DNA. The titra-
tion profile was integrated and corrected for the heat of 
dilution, which was estimated by a separate experiment by 
injecting the PFOS into the B-R buffer. The corrected heat 
was divided by the moles of injectant, and values were plot-
ted as a function of the PFOS/SA and PFOS/DNA molar 
ratio. The titration curve was fitted by a nonlinear least 
squares method.
Cartoon illustrating the possible binding sites of PFOS in SA  (A) and DNA (B) Figure 6
Cartoon illustrating the possible binding sites of 
PFOS in SA (A) and DNA (B).BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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PFOS binds to the surface of SA via electrostatic attraction
between the sulfonic acid group of PFOS and -NH3
+ of Lys
and Arg residues of SA (Fig. 6A). After the binding sites of
SA surface had been occupied, PFOS molecules entered
the cavity of SA easily (Fig. 6A). When cL0/cM0 > 10, the
heat released from the PFOS-SA interaction was positive,
indicating the occurrence of endothermic reaction and
hydrophobic interaction. Because the hydrophobic inter-
action is more likely to occur inside of the hydrophobic
cavity of SA, it is suggested that PFOS enters hydrophobic
cavity of SA and binds to the nonpolar AARs there. For
example, PFOS interacts with the aromatic side group of
Trp residue of SA. Owing to the small cavity where inside
binding occurred and the consequent effect on SA confor-
mation, SA folds and its conformation changes.
As is shown in Fig. 5B, ΔH is very small. Most of the heat
released from the PFOS-DNA interaction was positive,
indicating the occurrence of endothermic reaction and
hydrophobic interaction. PFOS probably interacts hydro-
phobically with the homolateral bases of DNA via the
alkyl group, paralleling with the phosphate backbones of
DNA (Fig. 6B). The conformation of DNA changed owing
to the hydrophobic interaction that pulls the contiguous
bps closer. This is confirmed from high ΔS values (Fig. 5B-
2).
Effects of PFOS on the physiological function of SA to 
transport Vitamin B2
The relationship between structural transformation of
protein and its functioning is of great significance in
organisms. During interaction process, a small organic
compound may bind to the peptide chain, regulating its
three-dimensional structure and even changing its corre-
sponding function [80,81]. Although non-covalent bind-
ing is often weak and non-specific, a combination of
many non-covalent bonds may alter the conformation
and function of the protein [82]. Serum albumin is the
most abundant protein of blood plasma. It is responsible
for the maintenance of both the oncotic pressure and pH
of blood. Moreover, it is the major plasma carrier protein
in blood which can bind a large number of ligands, e.g.,
amino acids, vitamins, fatty acids, drugs and so on.
The effects of PFOS on SA function were determined as
shown in Fig. 7. With the addition of PFOS, the binding
ratio of VB2 to SA decreases obviously comparing to that
in the absence of the pollutants and it indicates the inhi-
bition of SA carriage capacity by the pollutants. At the nor-
mal physiological condition, 1.2 mmol/l PFOS reduces
the binding ratio of VB2 to SA by more than 30%. It's
likely that the competition of binding sites in SA by pol-
lutants and VB2 and the subsequent conformation change
of SA are unfavorable for the binding of VB2 to SA. There-
fore, non-covalent binding of the organic compound
severely affects the physiological function of protein by
altering its conformation and overlapping its active sites.
Conclusion
By characterizing the interaction of PFOS with SA and
DNA using various methods, some important results were
obtained concerning e.g., binding number, binding
energy, and type of binding. The interactions of PFOS
with SA and DNA obeyed the Langmuir isothermal model
and the saturation mole numbers of PFOS was calculated
to be 45 per molecule of SA and 0.36 per bp of DNA.
These numbers indicate that PFOS has a high binding
capacity especially for SA in vitro. As to the toxicity of
PFOS in vivo at concentrations currently observed in the
environment, further research needs to be conducted.
Both the interactions are driven by entropy increase and
spontaneous. The electrostatic attraction and hydropho-
bic interaction are suggested to occur in PFOS binding to
the peptide chain and the grooves of DNA. The combined
action of non-covalent bonds results in change of the sec-
ondary structure of both SA and DNA, with the binding
ratio of VB2 to SA being reduced by more than 30%, indi-
cating the transport function of SA was inhibited conse-
quently. This work provides a useful experimental
method for studying the interaction of PFCs with biomac-
romolecules so as to understand the toxigenicity of PFCs.
Effect of PFOS on the physiological function of SA to trans- port VB2 Figure 7
Effect of PFOS on the physiological function of SA to 
transport VB2. All solutions contained 0.02 mmol/l SA and 
0.04 mmol/l VB2 at pH 7.40 at 37 °C in the presence of 0.15 
mol/l NaCl.BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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Methods
Instruments and Materials
A Model F-4500 fluorospectrophotometer (Hitachi High-
Technologies Cooperation, Tokyo, Japan) was used for
the concentration measurement of vitamin B2 and fluo-
rescence measurement of protein solutions in the pres-
ence of PFOS. A Model Lambda-25 spectrometer (Perkin-
Elmer, Shelton, CT 06484, USA) was used to determine
the concentration of PFOS during the process of equilib-
rium dialysis. The spectrometer was computer-controlled
using UV WinLab software (Version 2.85.04). The Isother-
mal Titration Calorimetery (ITC) experiments were car-
ried out on a Model VP-ITC system (MicroCal Inc., USA)
with VPViewer 2000 (Version 1.04.0018). A Model J-715
CD spectropolarimeter (Jasco Instruments, Tokyo, Japan)
with secondary structure estimation-standard analysis
measurement software (715/No. B014460524, Jasco) was
used to determine the conformation of protein and DNA.
Model RC 30-5K semi-permeable membranes (Molecular
Weight Cut Off 5 KDa, Shanghai Green Bird STD) were
used for equilibrium dialysis. A Model DK-8D electrother-
mic multiporous constant temperature water-bath
(Shanghai Yiheng Technol., Shanghai, China) was used in
the temperature experiment. Solution pHs were measured
with a Model pHS-25 acidity meter (Shanghai Precise Sci.
Instrum., Shanghai, China). An Accela U-HPLC-system
connected to a TSQ Quantum Access mass spectrometer
(Thermo Fisher Scientific, America) was used to validate
the CPC-ECR colorimetric method used for PFOS deter-
mination in this study.
Both 0.100 mmol/l SA (Sigma, A7906) and 3.7 mmol/l
bps of DNA (Shanghai Chemical Reagents Company,
Shanghai, China) were prepared in deionized water as a
stock solution and stored at 4°C. The precise concentra-
tion of protein and DNA were determined by the UV
method. PFOS stock solution (10 mmol/l) was prepared
by diluting 1 ml of PFOS water solution (40% in water,
Fluka, USA) in 100 ml of deionized water and stored at
4°C. Vitamin B2 stock solution (0.1276 mmol/l) was pre-
pared by dissolving 12 mg of Vitamin B2 (VB2) (purity
99%, Shanghai Chemical Reagents Company, Shanghai,
China) in 250 ml of deionized water and stored at 4°C.
The 1.25 mol/l NaCl and Britton-Robinson (B-R) buffer
(pH 7.40) containing 0.040 mol/l phosphoric acid, acetic
acid and boric acid was used for the experiments.
Determination of PFOS with CPC and ECR
PFOS reacts with cetylpyridinium chloride (CPC) by ion-
pair binding to form the PFOS-CPC complex [83]. The
anionic ligand, eriochrome cyanine R (ECR) was used to
replace CPC from the PFOS-CPC complex to form a CPC-
ECR complex. The color change was used for determina-
tion of PFOS only in this work. The replacement proce-
dures are followed. 2.0 ml pH 3.80 acetate buffer, 0.30 ml
1.00 mM CPC and 0.50 ml 1.00 mM ECR were mixed in
5-ml calibrated flasks. After mixing for 15 min, various
amounts of PFOS were added and the solutions diluted to
5 ml. After 10 min, the absorbance of each solution was
measured at 626 nm against a reagent blank without
PFOS.
Equilibrium of PFOS dialysis and working curve of PFOS 
determination
A schematic diagram of equilibrium dialysis experiment
was shown in Fig. 8. For equilibrium dialysis assay of
PFOS, 12.5 ml mother liquor containing 2.5 ml of B-R
buffer, 0.15 mol/l NaCl, a known volume of PFOS and
deionized water was pipeted into dialysis bags (1). 37.5
ml of the dialysate solution containing 0.15 mol/l NaCl,
7.5 ml of B-R buffer and deionized water was added to the
dialysis bag (3). The temperature of the water bath (4) was
kept constant at 37°C by adjusting the thermostat mag-
netic stirrer (5). 1 ml of the dialysis solution (3) was col-
lected into 5-ml calibrated flask every 2 h from the
sampling tube (6). According the above detection
method, the PFOS concentrations (cL) of the dialysis solu-
tions were determined. Variation of cL with the dialysis
The device designed for equilibrium dialysis Figure 8
The device designed for equilibrium dialysis. (1) – 
semi-permeable membrane with 12.5 ml of dialysate; (2) – 
the temperature sensor for maintaining the reaction at con-
stant 37°C; (3) – Dialysis solution 37.5 ml; (4) – water bath at 
constant 37°C. The apparatus was placed on a thermostated 
magnetic stirrer (5) and rotary magnets were used to mix 
solutions (3) and (4) thoroughly. The PFOS concentration in 
solution (3) was determined from the sampling tube (6).BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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time was shown in Fig. 9B. The dialysis of PFOS remains
at equilibrium between 8 and 12 h. After dialysis for 10
hours, 1 ml of the dialysis solution (3) was collected in 5-
ml calibrated flasks from every sampling tube (6). Accord-
ing to the detection method above, the absorbance of the
dialysis solution was measured at 626 nm. The working
standard curve of PFOS was established as shown in Fig.
9A. By five repetitive determinations of 0.200 mmol/l
PFOS, the result was 0.199 ± 0.006 mmol/l PFOS. The
recovery rates of the detection method are between 96.5
and 102% and the relative standard deviation 3%. The
detection method was used for the determination of PFOS
in the dialysis equilibrium solution, where no compli-
cated interference substance co-existed.
To validate the above detection method, a high perform-
ance liquid chromatography (HPLC) system coupled to a
triple quadrupole mass spectrometer (MS) was used with
the method being modified [31] (Additional File 2). After
equilibrium dialysis of 100.0, 150.0, 200.1 mg/l PFOS in
SA presence at 37°C for 10 hours, 1.00 ml of the dialysis
solution was collected and determined by the above
detection method. Meanwhile, another 1.00 ml of the
dialysis solution was also collected and determined by
HPLC-MS after being diluted for 1000 times. Then a total
of 10 μl was injected onto a Hypersil Gold C18 column
(150 × 2.1 mm, 5 μm, Thermo) with a 5 mM ammonium
acetate (pH 3.5)/methanol mobile phase starting at 10%
methanol. At a flow rate of 250 μL/min, the gradient
increased to 95% methanol at 13 min before reverting to
original conditions at 16 min. Column temperature was
maintained at 25°C. For quantitative determination, the
HPLC system was interfaced to a TSQ Quantum Access
(Thermo) mass spectrometer employing electron spray
ionization in the negative ion mode and highly selective
reaction monitoring. The fragment ions for PFOS m/z 499
(C8F17SO3
-) were monitored for quantification.
Equilibrium dialysis of PFOS in SA and DNA presences
In order to determine the interactions of PFOS with SA or
DNA, B-R buffer, 0.15 mol/l NaCl, a known volume of SA
or DNA solution (cM0), deionized water and a known vol-
ume of PFOS solution (cL0) were added in dialysis bags
(1). The temperature (2) of the water bath (4) was kept
constant at 37°C. Using the same method, 1 ml of the
dialysis solution (3) was collected in 5-ml calibrated
flasks from every sampling tube (6). According to the
detection method above, the absorbance of the dialysis
solution was measured at 626 nm and cL of PFOS was cal-
culated by the working curve. γ of PFOS to SA or DNA was
calculated and data were plotted.
Fluorescence measurement of PFOS-SA solutions
The B-R buffer (2.00 ml) and 0.050 ml of 0.100 mmol/l
SA were mixed with 0, 2.5, 5, 7.5, 10, 12.5, 15, 17.5 μmol/
l of PFOS in 10-ml calibrated flasks. The solutions were
diluted to 10 ml with deionized water and their fluores-
cence intensities were measured at the excitation wave-
length (280 nm) and the emission wavelengths (300–450
nm).
CD measurement of SA and DNA conformation in the 
presence of PFOS
The B-R Buffer (1 ml), 0.04 ml SA (0.100 mmol/l) were
mixed with 0, 16, 20, 24, 40 μmol/l PFOS in flasks. The
solutions were diluted to 10.0 ml with deionized water.
Each sample was allowed to equilibrate for 15 min before
measurement. CD spectra were taken on a spectropola-
rimeter with a 0.1 cm light path cell at 25°C. The mean
residue ellipticity (θ) of SA was measured between 190
and 240 nm. From the θ curves, the relative contents of
secondary structure forms of SA, α-helix, β-pleated sheet,
β-turn and random coil, were calculated in all solutions.
The 100 μmol/l DNA containing 0, 20, 30 and 40 μmol/l
PFOS were measured between 190 and 240 nm using the
same method.
ITC characterization of interactions of PFOS with SA and 
DNA
ITC experiments were carried out as follows: the PFOS
solution (2.50 mmol/l in pH 7.40 B-R buffer) was injected
about 27 times in 10-μl increments at 270-S intervals into
the isothermal cell containing SA (0.010 mmol/l in pH
7.40 B-R buffer) or DNA (0.500 mmol/l in pH 7.40 B-R
buffer). The cell temperature was kept at 37°C. Heats of
dilution of PFOS, obtained separately by injecting PFOS
into the buffer, were used to correct the raw data. The cor-
rected heats were divided by the number of moles injected
(A) Working curve for determination of PFOS between 0  and 1.60 mmol/l according to the dialysis procedures at pH  7.40 in 0.15 mol/l NaCl and the detection method with CPC  and ECR, measured at 626 nm Figure 9
(A) Working curve for determination of PFOS 
between 0 and 1.60 mmol/l according to the dialysis 
procedures at pH 7.40 in 0.15 mol/l NaCl and the 
detection method with CPC and ECR, measured at 
626 nm. (B) Effect of dialysis time on recovery of PFOS in 
the mother liquor containing 0.40 mmol/l PFOS at pH 7.40 in 
0.15 mol/l NaCl.BMC Molecular Biology 2009, 10:16 http://www.biomedcentral.com/1471-2199/10/16
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and analyzed using the Origin software (version 7.0) sup-
plied by the manufacturer. The titration curve was fitted
by a nonlinear least-squares method and ΔH and ΔS were
determined.
Effect of PFOS on the physiological function of SA to 
transport Vitamin B2
The fluorescence intensity of Vitamin B2 (VB2) solution
was measured at the excitation wavelength (440 nm) and
the emission wavelength (525 nm) against deionized
water using fluorospectrophotometer. The determination
of the VB2-SA interaction was investigated according to
the same equilibrium dialysis method as described above.
For the equilibrium dialysis assay of PFOS-VB2-SA, 12.5
ml solution containing 2.5 ml of B-R buffer, 0.15 mmol/l
NaCl, 0.02 mmol/l SA (cM0), 0.041 mmol/l VB2, a known
volume of PFOS solution (cL0) and deionized water were
pipeted into the dialysis bag (Fig. 8). After 10 hours at
37°C, 2.5 ml of the dialysis solution was collected from
the sampling tube and the concentration of VB2 was deter-
mined. The binding ratio of VB2 to SA was calculated to
investigate the effect of PFOS on the transport function of
SA.
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